Tobacco Tax Increases: A Discourse Analysis of the French Print and Web News Media from 2000 to 2020

Int J Environ Res Public Health. 2022 Nov 17;19(22):15152. doi: 10.3390/ijerph192215152.

Abstract

Lobbying led by the tobacco industry and tobacconists is a barrier to reducing smoking prevalence in France. Here, we analyze the discourse of the tobacco industry and other key actors (public health agencies, politicians, etc.) in the French general-audience news media from 2000 to 2020 around tobacco tax increases, which is one of the most effective tobacco control measures, especially amongst youth. We queried Europresse (a European news media and specialized press database) using the keywords "increase", "price or taxes", and "tobacco or cigarettes", and found 5409 topic-relevant articles, from which we extracted 8015 arguments for or against the measure. In total,64.3% were against the measure (mostly on grounds of "ufueling the black market"), 32.1% were for the measure (mostly claiming it is "effective at reducing smoking prevalence"), and 1.8% proposed alternative measures. Tobacconists, the primary source of media content on the topic, led a discourse that was strongly opposed to tax increases. Public health agencies, which attracted only half as much media attention, were strongly supportive of the measure. Analysis of discourses relayed in the French general-audience press revealed overwhelming opposition to tobacco tax increases, and this discourse was widely advanced by tobacconists. The results were congruent with international literature that had highlighted a similar set of arguments to those found in the French general press that were broadcasted by the tobacco industry and its allies (tobacconists in France) in an effort to block this evidence-based public health measure.

Keywords: French general press; arguments; discourse analysis; tobacco tax increases; tobacconists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Nicotiana
  • Taxes
  • Tobacco Industry*
  • Tobacco Products*
  • Tobacco Use

Grants and funding

This work was supported by Grant No. TABAC18-006_FP FELITAF from the French National Cancer Institute and the French Institute for Public Health Research.